HEADER ISOMERASE 19-JUN-09 3HX8 TITLE CRYSTAL STRUCTURE OF PUTATIVE KETOSTEROID ISOMERASE (NP_103587.1) FROM TITLE 2 MESORHIZOBIUM LOTI AT 1.45 A RESOLUTION COMPND MOL_ID: 1; COMPND 2 MOLECULE: PUTATIVE KETOSTEROID ISOMERASE; COMPND 3 CHAIN: A, B, C, D; COMPND 4 FRAGMENT: SEQUENCE DATABASE RESIDUES 23-150; COMPND 5 SYNONYM: MLR2180 PROTEIN; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MESORHIZOBIUM LOTI; SOURCE 3 ORGANISM_TAXID: 381; SOURCE 4 GENE: MLR2180, NP_103587.1; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: HK100; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: SPEEDET KEYWDS NP_103587.1, PUTATIVE KETOSTEROID ISOMERASE, STRUCTURAL GENOMICS, KEYWDS 2 JOINT CENTER FOR STRUCTURAL GENOMICS, JCSG, PROTEIN STRUCTURE KEYWDS 3 INITIATIVE, PSI-2, ISOMERASE EXPDTA X-RAY DIFFRACTION AUTHOR JOINT CENTER FOR STRUCTURAL GENOMICS (JCSG) REVDAT 4 01-FEB-23 3HX8 1 REMARK SEQADV REVDAT 3 24-JUL-19 3HX8 1 REMARK LINK REVDAT 2 25-OCT-17 3HX8 1 REMARK REVDAT 1 07-JUL-09 3HX8 0 JRNL AUTH JOINT CENTER FOR STRUCTURAL GENOMICS (JCSG) JRNL TITL CRYSTAL STRUCTURE OF PUTATIVE KETOSTEROID ISOMERASE JRNL TITL 2 (NP_103587.1) FROM MESORHIZOBIUM LOTI AT 1.45 A RESOLUTION JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 1.45 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.5.0053 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD WITH PHASES REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.45 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 28.03 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 95.4 REMARK 3 NUMBER OF REFLECTIONS : 83844 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.149 REMARK 3 R VALUE (WORKING SET) : 0.147 REMARK 3 FREE R VALUE : 0.186 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 4214 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.45 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.49 REMARK 3 REFLECTION IN BIN (WORKING SET) : 5516 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 89.83 REMARK 3 BIN R VALUE (WORKING SET) : 0.2430 REMARK 3 BIN FREE R VALUE SET COUNT : 306 REMARK 3 BIN FREE R VALUE : 0.2920 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3839 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 116 REMARK 3 SOLVENT ATOMS : 628 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 18.22 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 23.58 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.68000 REMARK 3 B22 (A**2) : 0.60000 REMARK 3 B33 (A**2) : 0.13000 REMARK 3 B12 (A**2) : 0.49000 REMARK 3 B13 (A**2) : 0.04000 REMARK 3 B23 (A**2) : -0.67000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.080 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.068 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.046 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 2.719 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.976 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.965 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 4190 ; 0.016 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): 2908 ; 0.001 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 5685 ; 1.524 ; 1.953 REMARK 3 BOND ANGLES OTHERS (DEGREES): 7115 ; 0.888 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 573 ; 6.124 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 190 ;28.561 ;24.947 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 718 ;13.321 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 22 ;24.316 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 585 ; 0.094 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 4825 ; 0.008 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 871 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2621 ; 1.581 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 1080 ; 0.692 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 4162 ; 2.487 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1569 ; 3.504 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1489 ; 5.076 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): 7096 ; 1.599 ; 3.000 REMARK 3 SPHERICITY; FREE ATOMS (A**2): 710 ; 8.187 ; 3.000 REMARK 3 SPHERICITY; BONDED ATOMS (A**2): 6983 ; 3.684 ; 3.000 REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: 1. HYDROGENS HAVE BEEN ADDED IN THE REMARK 3 RIDING POSITIONS. 2. A MET-INHIBITION PROTOCOL WAS USED FOR REMARK 3 SELENOMETHIONINE INCORPORATION DURING PROTEIN EXPRESSION. THE REMARK 3 OCCUPANCY OF THE SE ATOMS IN THE MSE RESIDUES WAS REDUCED TO REMARK 3 0.75 FOR THE REDUCED SCATTERING POWER DUE TO PARTIAL S-MET REMARK 3 INCORPORATION. 3. PEG (PG4) AND IMIDAZOLE (IMD) MOLECULES FROM REMARK 3 THE CRYSTALLIZATION / PROTEIN BUFFER SOLUTIONS ARE MODELED. AN REMARK 3 UNKNOWN LIGAND (UNL) IS MODELED IN EACH PROTOMER. REMARK 4 REMARK 4 3HX8 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 24-JUN-09. REMARK 100 THE DEPOSITION ID IS D_1000053693. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 19-MAR-09 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRL REMARK 200 BEAMLINE : BL9-2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.91162,0.97929,0.97915 REMARK 200 MONOCHROMATOR : DOUBLE CRYSTAL MONOCHROMATOR REMARK 200 OPTICS : FLAT COLLIMATING MIRROR, TOROID REMARK 200 FOCUSING MIRROR REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 325 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 83844 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.450 REMARK 200 RESOLUTION RANGE LOW (A) : 28.028 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 94.5 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : 0.04100 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 9.0500 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.45 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.50 REMARK 200 COMPLETENESS FOR SHELL (%) : 87.8 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.45200 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.300 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: MAD REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MAD REMARK 200 SOFTWARE USED: SHELX, SHELXD, AUTOSHARP REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 45.25 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.25 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 30.0000% PEG-6000, 0.1M MES PH 6.0, REMARK 280 NANODROP, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: SIZE EXCLUSION CHROMATOGRAPHY SUPPORTS THE ASSIGNMENT OF A REMARK 300 DIMER AS THE SIGNIFICANT OLIGOMERIZATION STATE. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4420 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 11780 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -11.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4650 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 11790 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -6.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 LYS A 150 REMARK 465 GLY B 0 REMARK 465 GLN B 23 REMARK 465 GLY C 0 REMARK 465 GLN C 23 REMARK 465 SER C 24 REMARK 465 LYS D 150 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 131 CE NZ REMARK 470 GLU B 27 CG CD OE1 OE2 REMARK 470 LYS B 114 CG CD CE NZ REMARK 470 ASP B 115 CG OD1 OD2 REMARK 470 SER B 116 OG REMARK 470 LYS B 117 CG CD CE NZ REMARK 470 GLU C 27 CG CD OE1 OE2 REMARK 470 LYS C 114 CG CD CE NZ REMARK 470 ASP C 115 CG OD1 OD2 REMARK 470 SER C 116 OG REMARK 470 LYS C 117 CG CD CE NZ REMARK 470 GLN C 133 CG CD OE1 NE2 REMARK 470 LYS C 150 CD CE NZ REMARK 470 LYS D 38 CE NZ REMARK 470 GLN D 70 CD OE1 NE2 REMARK 470 LYS D 131 CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 CE MSE B 82 O16 UNL B 200 2.12 REMARK 500 C5 PG4 D 3 O HOH D 630 2.15 REMARK 500 CG GLN C 70 O HOH C 389 2.16 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG B 65 NE - CZ - NH1 ANGL. DEV. = 3.8 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP B 115 0.97 -56.39 REMARK 500 SER B 116 -5.38 68.18 REMARK 500 SER C 116 -2.06 62.49 REMARK 500 REMARK 500 REMARK: NULL REMARK 610 REMARK 610 MISSING HETEROATOM REMARK 610 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 610 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 610 I=INSERTION CODE): REMARK 610 M RES C SSEQI REMARK 610 PG4 C 1 REMARK 610 PG4 C 2 REMARK 610 PG4 D 3 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE UNL A 200 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE IMD A 4 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE IMD A 5 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE UNL B 200 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE UNL C 200 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PG4 C 1 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PG4 C 2 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE UNL D 200 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PG4 D 3 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE IMD D 6 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 396313 RELATED DB: TARGETDB REMARK 999 REMARK 999 SEQUENCE REMARK 999 SEQUENCE THIS CONSTRUCT (RESIDUES 23-150) WAS EXPRESSED WITH A REMARK 999 PURIFICATION TAG MGSDKIHHHHHHENLYFQG. THE TAG WAS REMOVED WITH TEV REMARK 999 PROTEASE LEAVING ONLY A GLYCINE (0) FOLLOWED BY THE TARGET SEQUENCE. DBREF 3HX8 A 23 150 UNP Q98IZ3 Q98IZ3_RHILO 23 150 DBREF 3HX8 B 23 150 UNP Q98IZ3 Q98IZ3_RHILO 23 150 DBREF 3HX8 C 23 150 UNP Q98IZ3 Q98IZ3_RHILO 23 150 DBREF 3HX8 D 23 150 UNP Q98IZ3 Q98IZ3_RHILO 23 150 SEQADV 3HX8 GLY A 0 UNP Q98IZ3 EXPRESSION TAG SEQADV 3HX8 GLY B 0 UNP Q98IZ3 EXPRESSION TAG SEQADV 3HX8 GLY C 0 UNP Q98IZ3 EXPRESSION TAG SEQADV 3HX8 GLY D 0 UNP Q98IZ3 EXPRESSION TAG SEQRES 1 A 129 GLY GLN SER ALA LYS GLU ALA ILE GLU ALA ALA ASN ALA SEQRES 2 A 129 ASP PHE VAL LYS ALA TYR ASN SER LYS ASP ALA ALA GLY SEQRES 3 A 129 VAL ALA SER LYS TYR MSE ASP ASP ALA ALA ALA PHE PRO SEQRES 4 A 129 PRO ASP MSE ALA ARG VAL ASP GLY ARG GLN ASN ILE GLN SEQRES 5 A 129 LYS LEU TRP GLN GLY ALA MSE ASP MSE GLY ILE SER GLU SEQRES 6 A 129 LEU LYS LEU THR THR LEU ASP VAL GLN GLU SER GLY ASP SEQRES 7 A 129 PHE ALA PHE GLU SER GLY SER PHE SER LEU LYS ALA PRO SEQRES 8 A 129 GLY LYS ASP SER LYS LEU VAL ASP ALA ALA GLY LYS TYR SEQRES 9 A 129 VAL VAL VAL TRP ARG LYS GLY GLN ASP GLY GLY TRP LYS SEQRES 10 A 129 LEU TYR ARG ASP ILE TRP ASN SER ASP PRO ALA LYS SEQRES 1 B 129 GLY GLN SER ALA LYS GLU ALA ILE GLU ALA ALA ASN ALA SEQRES 2 B 129 ASP PHE VAL LYS ALA TYR ASN SER LYS ASP ALA ALA GLY SEQRES 3 B 129 VAL ALA SER LYS TYR MSE ASP ASP ALA ALA ALA PHE PRO SEQRES 4 B 129 PRO ASP MSE ALA ARG VAL ASP GLY ARG GLN ASN ILE GLN SEQRES 5 B 129 LYS LEU TRP GLN GLY ALA MSE ASP MSE GLY ILE SER GLU SEQRES 6 B 129 LEU LYS LEU THR THR LEU ASP VAL GLN GLU SER GLY ASP SEQRES 7 B 129 PHE ALA PHE GLU SER GLY SER PHE SER LEU LYS ALA PRO SEQRES 8 B 129 GLY LYS ASP SER LYS LEU VAL ASP ALA ALA GLY LYS TYR SEQRES 9 B 129 VAL VAL VAL TRP ARG LYS GLY GLN ASP GLY GLY TRP LYS SEQRES 10 B 129 LEU TYR ARG ASP ILE TRP ASN SER ASP PRO ALA LYS SEQRES 1 C 129 GLY GLN SER ALA LYS GLU ALA ILE GLU ALA ALA ASN ALA SEQRES 2 C 129 ASP PHE VAL LYS ALA TYR ASN SER LYS ASP ALA ALA GLY SEQRES 3 C 129 VAL ALA SER LYS TYR MSE ASP ASP ALA ALA ALA PHE PRO SEQRES 4 C 129 PRO ASP MSE ALA ARG VAL ASP GLY ARG GLN ASN ILE GLN SEQRES 5 C 129 LYS LEU TRP GLN GLY ALA MSE ASP MSE GLY ILE SER GLU SEQRES 6 C 129 LEU LYS LEU THR THR LEU ASP VAL GLN GLU SER GLY ASP SEQRES 7 C 129 PHE ALA PHE GLU SER GLY SER PHE SER LEU LYS ALA PRO SEQRES 8 C 129 GLY LYS ASP SER LYS LEU VAL ASP ALA ALA GLY LYS TYR SEQRES 9 C 129 VAL VAL VAL TRP ARG LYS GLY GLN ASP GLY GLY TRP LYS SEQRES 10 C 129 LEU TYR ARG ASP ILE TRP ASN SER ASP PRO ALA LYS SEQRES 1 D 129 GLY GLN SER ALA LYS GLU ALA ILE GLU ALA ALA ASN ALA SEQRES 2 D 129 ASP PHE VAL LYS ALA TYR ASN SER LYS ASP ALA ALA GLY SEQRES 3 D 129 VAL ALA SER LYS TYR MSE ASP ASP ALA ALA ALA PHE PRO SEQRES 4 D 129 PRO ASP MSE ALA ARG VAL ASP GLY ARG GLN ASN ILE GLN SEQRES 5 D 129 LYS LEU TRP GLN GLY ALA MSE ASP MSE GLY ILE SER GLU SEQRES 6 D 129 LEU LYS LEU THR THR LEU ASP VAL GLN GLU SER GLY ASP SEQRES 7 D 129 PHE ALA PHE GLU SER GLY SER PHE SER LEU LYS ALA PRO SEQRES 8 D 129 GLY LYS ASP SER LYS LEU VAL ASP ALA ALA GLY LYS TYR SEQRES 9 D 129 VAL VAL VAL TRP ARG LYS GLY GLN ASP GLY GLY TRP LYS SEQRES 10 D 129 LEU TYR ARG ASP ILE TRP ASN SER ASP PRO ALA LYS MODRES 3HX8 MSE A 53 MET SELENOMETHIONINE MODRES 3HX8 MSE A 63 MET SELENOMETHIONINE MODRES 3HX8 MSE A 80 MET SELENOMETHIONINE MODRES 3HX8 MSE A 82 MET SELENOMETHIONINE MODRES 3HX8 MSE B 53 MET SELENOMETHIONINE MODRES 3HX8 MSE B 63 MET SELENOMETHIONINE MODRES 3HX8 MSE B 80 MET SELENOMETHIONINE MODRES 3HX8 MSE B 82 MET SELENOMETHIONINE MODRES 3HX8 MSE C 53 MET SELENOMETHIONINE MODRES 3HX8 MSE C 63 MET SELENOMETHIONINE MODRES 3HX8 MSE C 80 MET SELENOMETHIONINE MODRES 3HX8 MSE C 82 MET SELENOMETHIONINE MODRES 3HX8 MSE D 53 MET SELENOMETHIONINE MODRES 3HX8 MSE D 63 MET SELENOMETHIONINE MODRES 3HX8 MSE D 80 MET SELENOMETHIONINE MODRES 3HX8 MSE D 82 MET SELENOMETHIONINE HET MSE A 53 8 HET MSE A 63 8 HET MSE A 80 8 HET MSE A 82 13 HET MSE B 53 8 HET MSE B 63 8 HET MSE B 80 8 HET MSE B 82 13 HET MSE C 53 8 HET MSE C 63 8 HET MSE C 80 8 HET MSE C 82 13 HET MSE D 53 8 HET MSE D 63 8 HET MSE D 80 8 HET MSE D 82 13 HET UNL A 200 23 HET IMD A 4 5 HET IMD A 5 5 HET UNL B 200 19 HET UNL C 200 16 HET PG4 C 1 10 HET PG4 C 2 10 HET UNL D 200 15 HET PG4 D 3 8 HET IMD D 6 5 HETNAM MSE SELENOMETHIONINE HETNAM UNL UNKNOWN LIGAND HETNAM IMD IMIDAZOLE HETNAM PG4 TETRAETHYLENE GLYCOL FORMUL 1 MSE 16(C5 H11 N O2 SE) FORMUL 6 IMD 3(C3 H5 N2 1+) FORMUL 10 PG4 3(C8 H18 O5) FORMUL 15 HOH *628(H2 O) HELIX 1 1 SER A 24 SER A 42 1 19 HELIX 2 2 ASP A 44 SER A 50 1 7 HELIX 3 3 GLY A 68 MSE A 82 1 15 HELIX 4 4 SER B 24 SER B 42 1 19 HELIX 5 5 ASP B 44 SER B 50 1 7 HELIX 6 6 GLY B 68 MSE B 82 1 15 HELIX 7 7 ALA C 25 SER C 42 1 18 HELIX 8 8 ASP C 44 SER C 50 1 7 HELIX 9 9 GLY C 68 MSE C 82 1 15 HELIX 10 10 SER D 24 SER D 42 1 19 HELIX 11 11 ASP D 44 SER D 50 1 7 HELIX 12 12 GLY D 68 MSE D 82 1 15 SHEET 1 A 6 VAL A 66 ASP A 67 0 SHEET 2 A 6 TYR A 52 PHE A 59 -1 N ALA A 58 O VAL A 66 SHEET 3 A 6 TRP A 137 SER A 146 1 O LEU A 139 N MSE A 53 SHEET 4 A 6 LEU A 118 LYS A 131 -1 N VAL A 128 O TYR A 140 SHEET 5 A 6 PHE A 100 PRO A 112 -1 N ALA A 101 O TRP A 129 SHEET 6 A 6 SER A 85 SER A 97 -1 N SER A 97 O PHE A 100 SHEET 1 B 6 VAL B 66 ASP B 67 0 SHEET 2 B 6 TYR B 52 PHE B 59 -1 N ALA B 58 O VAL B 66 SHEET 3 B 6 TRP B 137 ASP B 147 1 O LEU B 139 N MSE B 53 SHEET 4 B 6 LEU B 118 LYS B 131 -1 N ARG B 130 O LYS B 138 SHEET 5 B 6 PHE B 100 PRO B 112 -1 N ALA B 111 O VAL B 119 SHEET 6 B 6 SER B 85 SER B 97 -1 N SER B 97 O PHE B 100 SHEET 1 C 6 VAL C 66 ASP C 67 0 SHEET 2 C 6 TYR C 52 PHE C 59 -1 N ALA C 58 O VAL C 66 SHEET 3 C 6 TRP C 137 SER C 146 1 O LEU C 139 N MSE C 53 SHEET 4 C 6 LEU C 118 LYS C 131 -1 N VAL C 128 O TYR C 140 SHEET 5 C 6 PHE C 100 PRO C 112 -1 N ALA C 101 O TRP C 129 SHEET 6 C 6 SER C 85 SER C 97 -1 N SER C 97 O PHE C 100 SHEET 1 D 6 VAL D 66 ASP D 67 0 SHEET 2 D 6 TYR D 52 PHE D 59 -1 N ALA D 58 O VAL D 66 SHEET 3 D 6 TRP D 137 SER D 146 1 O LEU D 139 N MSE D 53 SHEET 4 D 6 LEU D 118 LYS D 131 -1 N VAL D 128 O TYR D 140 SHEET 5 D 6 PHE D 100 PRO D 112 -1 N GLU D 103 O VAL D 127 SHEET 6 D 6 SER D 85 SER D 97 -1 N SER D 97 O PHE D 100 LINK C TYR A 52 N MSE A 53 1555 1555 1.33 LINK C MSE A 53 N ASP A 54 1555 1555 1.33 LINK C ASP A 62 N MSE A 63 1555 1555 1.33 LINK C MSE A 63 N ALA A 64 1555 1555 1.33 LINK C ALA A 79 N MSE A 80 1555 1555 1.32 LINK C MSE A 80 N ASP A 81 1555 1555 1.33 LINK C ASP A 81 N MSE A 82 1555 1555 1.34 LINK C MSE A 82 N GLY A 83 1555 1555 1.33 LINK C TYR B 52 N MSE B 53 1555 1555 1.32 LINK C MSE B 53 N ASP B 54 1555 1555 1.33 LINK C ASP B 62 N MSE B 63 1555 1555 1.34 LINK C MSE B 63 N ALA B 64 1555 1555 1.33 LINK C ALA B 79 N MSE B 80 1555 1555 1.32 LINK C MSE B 80 N ASP B 81 1555 1555 1.32 LINK C ASP B 81 N MSE B 82 1555 1555 1.34 LINK C MSE B 82 N GLY B 83 1555 1555 1.33 LINK C TYR C 52 N MSE C 53 1555 1555 1.33 LINK C MSE C 53 N ASP C 54 1555 1555 1.34 LINK C ASP C 62 N MSE C 63 1555 1555 1.32 LINK C MSE C 63 N ALA C 64 1555 1555 1.34 LINK C ALA C 79 N MSE C 80 1555 1555 1.33 LINK C MSE C 80 N ASP C 81 1555 1555 1.32 LINK C ASP C 81 N MSE C 82 1555 1555 1.34 LINK C MSE C 82 N GLY C 83 1555 1555 1.33 LINK C TYR D 52 N MSE D 53 1555 1555 1.33 LINK C MSE D 53 N ASP D 54 1555 1555 1.33 LINK C ASP D 62 N MSE D 63 1555 1555 1.34 LINK C MSE D 63 N ALA D 64 1555 1555 1.32 LINK C ALA D 79 N MSE D 80 1555 1555 1.32 LINK C MSE D 80 N ASP D 81 1555 1555 1.34 LINK C ASP D 81 N MSE D 82 1555 1555 1.33 LINK C MSE D 82 N GLY D 83 1555 1555 1.33 SITE 1 AC1 17 IMD A 4 PHE A 36 PRO A 61 TRP A 76 SITE 2 AC1 17 PHE A 107 LEU A 109 TYR A 125 ASP A 142 SITE 3 AC1 17 TRP A 144 ASN A 145 SER A 146 HOH A 180 SITE 4 AC1 17 HOH A 210 HOH A 281 HOH B 13 PRO B 61 SITE 5 AC1 17 ASP B 62 SITE 1 AC2 6 ASN A 33 LEU A 89 TYR A 125 VAL A 127 SITE 2 AC2 6 LEU A 139 UNL A 200 SITE 1 AC3 3 GLU A 30 ASN A 33 LEU A 89 SITE 1 AC4 12 ASN B 33 PHE B 36 TRP B 76 MSE B 82 SITE 2 AC4 12 LEU B 89 GLU B 103 PHE B 107 TYR B 125 SITE 3 AC4 12 VAL B 127 ASP B 142 TRP B 144 HOH B 221 SITE 1 AC5 11 ASN C 33 PHE C 36 TRP C 76 MSE C 82 SITE 2 AC5 11 LEU C 89 GLU C 103 PHE C 107 LEU C 109 SITE 3 AC5 11 TYR C 125 ASP C 142 TRP C 144 SITE 1 AC6 16 ASP A 55 ASP A 67 GLY A 68 ASN A 71 SITE 2 AC6 16 HOH A 171 HOH A 226 HOH A 302 PG4 C 2 SITE 3 AC6 16 ASP C 55 ALA C 56 ASP C 67 GLY C 68 SITE 4 AC6 16 GLN C 70 ASN C 71 HOH C 389 HOH C 482 SITE 1 AC7 8 ASP A 67 ASP B 93 PG4 C 1 ARG C 65 SITE 2 AC7 8 ASP C 67 HOH C 607 SER D 104 HOH D 509 SITE 1 AC8 11 IMD D 6 PHE D 36 PRO D 61 TRP D 76 SITE 2 AC8 11 PHE D 107 TYR D 125 ASP D 142 TRP D 144 SITE 3 AC8 11 HOH D 529 HOH D 588 HOH D 614 SITE 1 AC9 11 LYS B 88 THR B 90 SER B 106 PHE B 107 SITE 2 AC9 11 SER B 108 ALA B 122 LYS B 150 LYS D 26 SITE 3 AC9 11 VAL D 94 HOH D 251 HOH D 630 SITE 1 BC1 6 ASN D 33 LEU D 89 GLU D 103 TYR D 125 SITE 2 BC1 6 VAL D 127 UNL D 200 CRYST1 48.336 55.111 56.862 69.02 76.89 64.83 P 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.020689 -0.009720 -0.002027 0.00000 SCALE2 0.000000 0.020048 -0.006228 0.00000 SCALE3 0.000000 0.000000 0.018908 0.00000